Sam Brusco, Associate Editor12.13.21
Homecare respiratory products maker Inogen appointed Mike Sergesketter as interim chief financial officer (CFO), effective immediately. Sergesketter was most recently CFO of Kimball Electronics. He replaces Alison Bauerlein, who will remain at the company in a transitional role through the first quarter of next year.
Inogen has employed an executive search firm to help seek a permanent replacement.
“The changes we have made to our executive team support our continued strategic evolution and our goal of transforming Inogen into a more prominent player in respiratory care,” Inogen president and CEO Neil Shabshab told the press. “I’m confident Mike’s strong experience in finance, strategic manufacturing and M&A, as well as his global perspective, will be a tremendous asset as we continue to execute against our plans. I am grateful for the time and collaboration I have had with Ali and want to thank her for her many contributions as a key member of the team that launched and grew Inogen. I wish her well in her future endeavors.”
Bauerlein added, “It has been an honor to work with such an exceptional and committed team over the past 20 years to help improve the lives of patients worldwide. As part of Inogen’s founding team, I am proud of our innovative and market-leading product portfolio, and I look forward to following Inogen’s continued evolution and success.”
Inogen has employed an executive search firm to help seek a permanent replacement.
“The changes we have made to our executive team support our continued strategic evolution and our goal of transforming Inogen into a more prominent player in respiratory care,” Inogen president and CEO Neil Shabshab told the press. “I’m confident Mike’s strong experience in finance, strategic manufacturing and M&A, as well as his global perspective, will be a tremendous asset as we continue to execute against our plans. I am grateful for the time and collaboration I have had with Ali and want to thank her for her many contributions as a key member of the team that launched and grew Inogen. I wish her well in her future endeavors.”
Bauerlein added, “It has been an honor to work with such an exceptional and committed team over the past 20 years to help improve the lives of patients worldwide. As part of Inogen’s founding team, I am proud of our innovative and market-leading product portfolio, and I look forward to following Inogen’s continued evolution and success.”